Patent intelligence · SA
SA 91110341
مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus
مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus
Patent details — SA 91110341
- Jurisdiction
- SA
- Status
- expired
- Grant date
- May 25, 2004
- Expiration
- May 20, 2024
- Applicant
- BEECHAM GROUP PLC [GB]
- CPC classes
- A61K 9/ 00 A I, A61K 9/ 08 A I, A61K 31/ 52 A I, A61K 47/ 10 A I
Quick answer
SA 91110341 (مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus) is held by BEECHAM GROUP PLC [GB]. Status: expired. Granted May 25, 2004. Expires May 20, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BEECHAM GROUP PLC [GB]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 00 A I, A61K 9/ 08 A I, A61K 31/ 52 A I, A61K 47/ 10 A I, A61K 47/ 34 A I, A61K/3152
More from BEECHAM GROUP PLC [GB]
Related pharmaceutical patents in our USPTO index.
-
SA 92120308
تركيبة للاستخدام الموضعي topical composition
expired -
AT E269330
CHEMISCHE VERBINDUNGEN
expired -
EP 1425277
HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG
expired -
HU P0302480
PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
expired -
AT E245157
3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
expired -
HK 1004528
Dentifrice compositions
expired -
HU P0204410
PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
expired
Frequently asked questions
What is US patent 91110341?
SA 91110341 (مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus) is held by BEECHAM GROUP PLC [GB]. Status: expired. Granted May 25, 2004. Expires May 20, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns SA 91110341?
BEECHAM GROUP PLC [GB] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does SA 91110341 expire?
Our index shows an expiration date of May 20, 2024 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.